OHP-002 Financial impact of the use of bevacizumab in the treatment of macular oedema secondary to retinal vein occlusion

ER Alfaro Lara; FJ Bautista Paloma; C Vázquez Marouschek; S Flores Moreno; A Villalba Moreno; MA Pérez Moreno

doi:10.1136/ejhpharm-2013-000436.454

Article info

Authors

ER Alfaro Lara 1Hospital Universitario Virgen del Rocio, Pharmacy, Seville, Spain PubMed articles Google scholar articles
FJ Bautista Paloma 1Hospital Universitario Virgen del Rocio, Pharmacy, Seville, Spain PubMed articles Google scholar articles
C Vázquez Marouschek 2Hospital Universitario Virgen del Rocio, Ophthalmology, Seville, Spain PubMed articles Google scholar articles
S Flores Moreno 1Hospital Universitario Virgen del Rocio, Pharmacy, Seville, Spain PubMed articles Google scholar articles
A Villalba Moreno 1Hospital Universitario Virgen del Rocio, Pharmacy, Seville, Spain PubMed articles Google scholar articles
MA Pérez Moreno 1Hospital Universitario Virgen del Rocio, Pharmacy, Seville, Spain PubMed articles Google scholar articles

Citation

Alfaro Lara E, Bautista Paloma F, Vázquez Marouschek C, et al

OHP-002 Financial impact of the use of bevacizumab in the treatment of macular oedema secondary to retinal vein occlusion

European Journal of Hospital Pharmacy 2014;21:A185.

Publication history

First published February 24, 2014.

Online issue publication

September 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password